Approval · Notice of Compliance 28358 · 2022
BIO-FINASTERIDE: Notice of Compliance 28358
Issued June 9, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28358
- Date
- June 9, 2022
- Company
- Biomed PharmaMontreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Administrative: Licensing Agreement Between Two Companies
- Canadian reference product
- PROSCAR (Merck Frosst Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BIO-FINASTERIDE | 02527847 | Marketed |
Medicinal ingredients
- FINASTERIDE 5 MG per TAB